In biotherapeutic process development, evaluating and tracking potential product quality attributes (PQAs) is crucial to ensure quality, safety and efficacy. Currently, multiple analytical assays are used for PQA monitoring throughout biologic development and production, which is resource intensive. You can streamline your workflows with a faster, more in depth view of your biologic with MAM using Accurate Mass LC-MS.
Access this info kit to learn more about:
- Using MAM to accelerate the development of antibody-drug conjugates
- Compliant attribute monitoring for biopharmaceutical product quality
- Charge variant liability analysis using the SCIEX flexible solution for MAM
